Prof. Dr. med. Dr. med. habil. Sigmund Silber
FESC, FACC, FAHA
Kardiologe

CURRICULUM VITAE

Sigmund Silber, MD, PhD
Professor of Medicine
FESC, FACC, FAHA
Cardiologist

sigmund@silber.com
www.sigmund-silber.com
Cardiology Practice and Heart Center at the Isar, Munich, Germany

Professional Experience and Academic Degrees

1968

B.S.-equivalent (Abitur at Rupprecht-Gymnasium, Munich, Germany)


1968 - 1974

Medical School at the University of Munich (Ludwig-Maximilians-University, LMU)


1970 - 1974

Research Associate
Institute for Experimental Cardiovascular Pharmacology, University of Munich


1975

Thesis (MD), Dissertation, Institute for Experimental Cardiovascular Pharmacology, University of Munich, Topic: "Effects of Aescin on the Circulation of the Cat", Magna cum Laude


1974-1975

Internships

  • Internal Medicine: Stiftsklinik Augustinum, Munich
  • (Director: Prof. Dr. med. D. Michel)

  • Gynecology: II. Frauenklinik of the Univ. of Munich
  • (Director: Prof. Dr. med. K. Richter)

  • General Surgery: Krankenhaus Munich-Schwabing
  • (Director: Dr. med. M. Schmid)

1975 - 1982

Residency and Fellowships German Heart Center, Munich (Director: Prof. Dr. med. W. Rudolph)


1982 - 1986

Assistant Professor Department of Internal Medicine, Division of Cardiology, Medizinische Klinik Innenstadt, Ludwig-Maximilians-University (LMU), Munich


1982 - 1986

Director, Nuclear Cardiology, University of Munich


1982 - 1986

Member, Isotope and Formulatory Committee, University of Munich


1982 - 1986

Director, ST-Segment Holter Monitoring Laboratory, University of Munich


1986

PhD-equivalent Thesis, („Habilitation“)
at the Ludwig-Maximilians-University, Munich (Prof. Dr. med. E. Buchborn)
Topic: "Nitrate Tolerance: Induction, Rational Circumvention and
Consequences for a Combination Therapy"


1987 - 1989

Associate Professor
Department of Medicine, Cardiology,
University of Alabama at Birmingham (UAB), USA (Director: G.M. Pohost)


1987 - 1989

Director, Holter Laboratory and Cardiac Pharmacology Clinic, UAB, USA


1990

Attending physician, Cardiology Associates at the Red Cross Hospital, Frankfurt/Main, Germany


1990

Associate Professor, Johann Wolfgang Goethe University of Frankfurt/Main, Germany


1996

Associate Professor, Ludwig-Maximilians-University (LMU), Munich


1998

Full Professor of Medicine at the Ludwig-Maximilians-University (LMU), Munich


Today

Private practice since 1991 (all insurances),
Cardiology Associates in Munich
and
Director, Heart Center at the Isar, Munich


Today

Academic Teaching Practice of the Ludwig-Maximilians-University, Munich
applying the MeCuM (Medical Curriculum Munich) Medical School Concept
for advanced medical students.

Medical Licensures and Board Certifications

1974

ECFMG #2254209 (for USA Medical License)


1975


1981


1984


1984


2003

Professional Memberships













Honorable Memberships


FAHA (Fellow of the American Heart Association)

Current Honorable Functions and Elected Positions


Executive Board, Quality Control of Invasive Procedures in Bavaria (BAQ)


Appointed Expert for Disease Management Programs (DMP) for CAD in Germany


Appointed Expert for National Guidelines for Chronic CAD in Germany


Member of the Nucleus of the Working Group „Cardiac CT“ of the DGK


President, Annual Symposium of p-c-i live in Munich


Associate Director, TCT


Editorial Board, EuroIntervention Journal


Editorial Board, Clinical Research in Cardiology Journal


Editor-in-Chief of the bilingual Journal „CCN“ (Cathlab and Cardiovascular News)

Previous Honorable Functions and Elected Positions

Chairman, PCI Guidelines of the European Society of Cardiology (ESC)



Vice President, German Society of Interventional Cardiology (BIK)


Chairman, Working Group of Interventional Cardiology (DGK)


Chairman, Working Group of Intracoronary Brachytherapy (DGK)



Member of the Guideline Committee of the German Cardiac Society (DGK)


Treasurer of the Board, European Council of Cardiology Practice (ECCP)


Member of the 3rd Task Force of the ESC for the Prevention of Cardiovascular Diseases


Member of the ESC Task Force for Implementation of the Guidelines for the Management of Heart Attacks


Chairman, PCI Guidelines of the European Society of Cardiology (ESC)


President, German Society of Cardiologists in Private Practice (BNK)


Vice President, German Society of Interventional Cardiology (BIK)


Chairman, Working Group of Interventional Cardiology (DGK)


Chairman, Working Group of Intracoronary Brachytherapy (DGK)


Member of the Committee for Practice Guidelines and Policy Conference of the ESC


Member of the Guideline Committee of the German Cardiac Society (DGK)


Treasurer of the Board, European Council of Cardiology Practice (ECCP)


Member of the 3rd Task Force of the ESC for the Prevention of Cardiovascular Diseases


Member of the ESC Task Force for Implementation of the Guidelines for the Management of Heart Attacks

Editorial Consultant for Peer Reviewed Journals

American Heart Journal


American Journal of Cardiology


American Journal of Medicine


Catheterization and Cardiovascular Intervention


Circulation


Clinical Cardiology


Clinical Research in Cardiology


Deutsche Medizinische Wochenschrift


EuroIntervention


European Heart Journal


Heart


International Journal of Cardiology


JACC


JAMA


Lancet

Participation in Clinical Multicenter Studies

A.A.C.H.E.N. (Angiotensin-II Antagonist to reduce post Coronary stent Hyperplasia of Endothelial Neointima)


ACUITY (A randomized comparison of bivalirudin vs. heparin and GP IIb/IIIa inhibitors in patients undergoing early invasive management for NSTE-ACS)



BETA-CATH (Beta Cath System Study for brachytherapy of de-novo coronary lesions)


BRIE (Beta Radiation In Europe), Principal Investigator for Germany


CAST (Cardiac Arrythmia Supression Trial)


CHARISMA (Clopidogrel for High Atherothrombotic Risk and Ischaemic Stabilization)


CYPHER (German Registry for prospective Evaluation and Follow-up of Patients after Cypher Stent Implantation)


DaVINCI (Registry for prospective Evaluation and Follow-up of Patients after Vision Stent Implantation)


DES.DE (German Drug-Eluting Stent Registry), Member of the Steering Committee


DETECT (Diabetes Cardiovaskular Risk-Evaluation), Member of the Steering Committee


DUETT (A Novel Vascular Sealing Device for Closure of Percutaneous Arterial Access Sites), Principal Investigator


EBEAT (Electron Beam Computed Tomography assessment of coronary calcification), Member of the Safety/Endpoint Committee (SEC)


ENDEAVOR II (Randomized, controlled trial to Evaluate the AVE ABT-578 Eluting Driver Sten)



EUROSTAR II (European prospective study of the COSTAR Paclitaxel-Eluting Coronary Stent System as compared to the bare stent), Principal Investigator


EVIDENT (Endovascular Investigation Determining the safety of new Tacrolimus-eluting stent grafts)


EVOLVE-II (Randomized Evaluation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent), Principal National Investigator



HEALING II + IIb (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth: Progenitor Endothelial Cells)



ISAR-PROJECT-2 (Clinical Evaluation of on-site coating with two Rapamycin dose regimes)


IST (Intracoronary Radiation Therapy), Principal Investigator


IT Biodegradable Study (The Biodegradable Poly-L-Lactic Acid Igaki-Tamai Coronary Stent), Principal Investigator


LUNAR ROX (Registry for prospective Evaluation of Patients after Lunar Rox Stent Implantation), Principal Investigator


LUSTY (Lunar Stent study), Principal Investigator


MASTER (The MGuard mesh-based Embolic Protection Stent for Acute ST-Elevation Reperfusion Trial), Co-Principal Investigator


MUNICH (Multislice Normal Incidence of Coronary Health), Principal Investigator


NOBORI-1 (Prospective, Randomized, Multi-Center Comparison of the Nobori and Taxus Drug Eluting Stent System), Member of the Steering Committee


NIRTOP ('Fused-Gold' vs. 'Bare' Stainless Steel NIRflex Stents), Member of the Steering Committee



OPEN II (Assessment of the STENTYS Paclitaxel-eluting selfexpanding stent in coronary bifurcation lesions)



PLATINUM PLUS (Randomized Multicenter Trial to Assess the Everolimus-Eluting Coronary Stent System), Co-Principal Investigator


RECALL (Heinz Nixdorf Recall Study), Advisory Board


REMEDEE (Randomized Study to Evaluate the Combo Abluminal Sirolimus Coated Bio-Engineered Stent)




RESOLUTE-AC (All-Comers Randomized Comparison of a Zotarolimus-Eluting Stent with an Everolimus-Eluting Stent for PCI), Co-Principal Investigator


REVEAL HPS 3 / TIMI 55 (Randomized Evaluation of Anacetrapib in pats. with established vascular disease for increasing HDL-Cholesterol)


SAFE (A global post-market surveillance for the Dexamethason eluting Stent)







TAXUS-VI (Randomized, double-blind study to assess paclitaxel-eluting stents in the treatment of longer lesions)


OLYMPIA (Global TAXUS Liberté Registry)


ZOMAXX I (Randomized Evaluation of the Zomaxx ABT 578-eluting stent compared to the Taxus Express Paclitaxel-Eluting Stent)